Oscar Health (NYSE:OSCR) Cut to “Hold” at Wall Street Zen

Wall Street Zen cut shares of Oscar Health (NYSE:OSCR) from a buy rating to a hold rating in a report published on Sunday morning.

Separately, Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Oscar Health presently has an average rating of “Hold” and a consensus price target of $16.50.

Oscar Health Stock Performance

NYSE OSCR opened at $14.67 on Friday. The firm has a market capitalization of $3.73 billion, a P/E ratio of -732.88 and a beta of 1.73. The firm’s fifty day moving average price is $13.93 and its two-hundred day moving average price is $14.52. Oscar Health has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company’s revenue was up 42.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 earnings per share. As a group, research analysts anticipate that Oscar Health will post 0.69 EPS for the current year.

Insider Buying and Selling

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now directly owns 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 24.39% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

Large investors have recently bought and sold shares of the company. Jones Financial Companies Lllp grew its stake in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio acquired a new stake in Oscar Health during the first quarter worth about $30,000. Larson Financial Group LLC grew its stake in Oscar Health by 83,733.3% during the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after buying an additional 2,512 shares in the last quarter. CWM LLC grew its stake in Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after buying an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock valued at $45,000 after purchasing an additional 2,854 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.